Hamps Bio Statistics

Total Valuation

Hamps Bio has a market cap or net worth of INR 206.95 million. The enterprise value is 219.73 million.

Market Cap	206.95M
Enterprise Value	219.73M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Hamps Bio has 4.36 million shares outstanding.

Current Share Class	4.36M
Shares Outstanding	4.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	71.99%
Owned by Institutions (%)	n/a
Float	1.22M

Valuation Ratios

The trailing PE ratio is 28.02.

PE Ratio	28.02
Forward PE	n/a
PS Ratio	3.20
PB Ratio	6.13
P/TBV Ratio	6.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.67, with an EV/FCF ratio of -33.62.

EV / Earnings	43.88
EV / Sales	3.39
EV / EBITDA	18.67
EV / EBIT	28.40
EV / FCF	-33.62

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.31.

Current Ratio	1.73
Quick Ratio	0.75
Debt / Equity	0.31
Debt / EBITDA	0.89
Debt / FCF	-1.60
Interest Coverage	5.40

Financial Efficiency

Return on equity (ROE) is 21.14% and return on invested capital (ROIC) is 12.86%.

Return on Equity (ROE)	21.14%
Return on Assets (ROA)	10.62%
Return on Invested Capital (ROIC)	12.86%
Return on Capital Employed (ROCE)	20.67%
Revenue Per Employee	887,027
Profits Per Employee	68,589
Employee Count	73
Asset Turnover	1.42
Inventory Turnover	2.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	49.71
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.52
Average Volume (20 Days)	4,700

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hamps Bio had revenue of INR 64.75 million and earned 5.01 million in profits. Earnings per share was 1.70.

Revenue	64.75M
Gross Profit	46.64M
Operating Income	7.74M
Pretax Income	6.50M
Net Income	5.01M
EBITDA	11.77M
EBIT	7.74M
Earnings Per Share (EPS)	1.70

Full Income Statement

Balance Sheet

The company has 584,000 in cash and 10.45 million in debt, giving a net cash position of -9.87 million or -2.27 per share.

Cash & Cash Equivalents	584,000
Total Debt	10.45M
Net Cash	-9.87M
Net Cash Per Share	-2.27
Equity (Book Value)	33.74M
Book Value Per Share	10.76
Working Capital	10.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.92 million and capital expenditures -3.62 million, giving a free cash flow of -6.54 million.

Operating Cash Flow	-2.92M
Capital Expenditures	-3.62M
Free Cash Flow	-6.54M
FCF Per Share	-1.50

Full Cash Flow Statement

Margins

Gross margin is 72.02%, with operating and profit margins of 11.95% and 7.73%.

Gross Margin	72.02%
Operating Margin	11.95%
Pretax Margin	10.04%
Profit Margin	7.73%
EBITDA Margin	18.18%
EBIT Margin	11.95%
FCF Margin	n/a

Dividends & Yields

Hamps Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.56%
Shareholder Yield	-84.56%
Earnings Yield	2.42%
FCF Yield	-3.16%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hamps Bio has an Altman Z-Score of 2.09. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.09
Piotroski F-Score	n/a